Trial intelligence / Profile preview

Montelukast for quality of life in adults with nasal polyps

IRCT20171230038142N15Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of montelukast in nasal polyp (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Quality of life, ICSD score and 2 more. Started Dec 2018; status: completed.

02

Drugs

montelukast
03

Conditions

nasal polyp

Beyond the preview

Go deeper on IRCT20171230038142N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171230038142N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call